Biosafety and Health ranks among top 25% of public health journals

The 2021 CiteScore of Biosafety and Health, an academic journal published by the China CDC, is 4.8 and its CiteScoreTracker 2022 is 5.7, ranking 124th and among the top 25% of 562 journals of the "Medicine: Public Health" discipline, according to Elsevier, which manages the metric.

 

Elsevier officially released the CiteScore 2021 values on June 8, 2022, having calculated them based on review of more than 27,200 journals included in its Scopus database.

 

The international influence of Biosafety and Health is rapidly increasing. The open access policy and publication quality of the journal meet the standards of international evaluation institutions. It has been collected by domestic and foreign databases, such as the DOAJ (Dictionary of Open Access Journals), the RCCSE (Research Center for Chinese Science Evaluation), the CSCD (Chinese Science Citation Database) and Scopus. Meanwhile, 74 papers on biosafety published in the journal have been included by PubMed Central (PMC).

 

CiteScore is a new journal evaluation system launched by Elsevier in December 2016. This metric evaluates the influence of peer-reviewed journals, book series, conference papers and industry journals included in the Scopus database in a range of four years. The citation count is accumulated from the year of publication to the end of the calculation date. It means that all citations are included in the CiteScore for a more comprehensive assessment.

 

Biosafety and Health is an open access, peer-reviewed journal sponsored by the Chinese Medical Association and managed by the China CDC's National Institute for Viral Disease Control and Prevention. The journal aims to publish original research findings and thoughts from any perspective connected with public health and biosafety. 

 

Topics include: Identification and characterization of biological threats; Origin, transmission, and evolution of biological agents; Surveillance, risk assessment, and early-warning; Prevention, diagnosis, and therapeutics; Synthetic biotechnology, genome editing, and other new biotechniques; Biosafety materials; Policies and standards.

 

The editorial board of Biosafety and Health is composed of eight academician consultants including Yunde Hou and George F. Gao and 78 well-known experts (44 Chinese editors and 34 international editors). The editor-in-chief of the journal is Guizhen Wu, chief biosafety expert of the China CDC and the current chairman of the Asia Pacific biosafety Association (A-PBA). The executive editor-in-chief of the journal is Jianwei Wang, biosafety expert of Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

 

The inaugural issue of the journal was published in June 2019. The editorial board of Biosafety and Health adhere to rigorous principles of publication, implement fair peer reviews, and publish cutting-edge scientific papers of only the highest quality. All papers are published online immediately after being accepted, and can be accessed for free.

 

Biosafety and Health Editorial Department

Tel: + 86 (10) 63586558

Contact: Tao Jiang

Email address: biosafetyandhealth@ivdc.chinacdc.cn  

Journal homepage: https://www.journals.elsevier.com/biosafety-and-health  

Submission link: https://www.editorialmanager.com/bsheal/Default.aspx